This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2019 Jan 31;133(5):498-501.

doi: 10.1182/blood-2018-10-878892. Epub 2018 Dec 7.

Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL

Affiliations

Affiliations

¹ Department of Advanced Biomedical Sciences and.
² Department of Clinical Medicine and Surgery, Federico II University Medical, School, Naples, Italy; and.
³ Department of Economics, University of Molise, Campobasso, Italy.

PMID: 30530802
PMCID: PMC6405330
DOI: 10.1182/blood-2018-10-878892

Comparative Study

Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL

Marco Picardi et al. Blood. 2019.

. 2019 Jan 31;133(5):498-501.

doi: 10.1182/blood-2018-10-878892. Epub 2018 Dec 7.

Affiliations

¹ Department of Advanced Biomedical Sciences and.
² Department of Clinical Medicine and Surgery, Federico II University Medical, School, Naples, Italy; and.
³ Department of Economics, University of Molise, Campobasso, Italy.

PMID: 30530802
PMCID: PMC6405330
DOI: 10.1182/blood-2018-10-878892

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Similar articles

Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.
Tseng CM, Chen TB, Hsu YC, Chang CY, Lin JT, Mo LR. Tseng CM, et al. Asia Pac J Clin Oncol. 2016 Dec;12(4):421-429. doi: 10.1111/ajco.12520. Epub 2016 Jul 20. Asia Pac J Clin Oncol. 2016. PMID: 27435683
Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.
Zhang MY, Zhu GQ, Zheng JN, Cheng Z, Van Poucke S, Shi KQ, Huang HH, Chen FY, Zheng MH. Zhang MY, et al. Expert Rev Anti Infect Ther. 2017 May;15(5):503-513. doi: 10.1080/14787210.2017.1309291. Epub 2017 Mar 29. Expert Rev Anti Infect Ther. 2017. PMID: 28317397 Review.
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Huang H, Li X, Zhu J, Ye S, Zhang H, Wang W, Wu X, Peng J, Xu B, Lin Y, Cao Y, Li H, Lin S, Liu Q, Lin T. Huang H, et al. JAMA. 2014 Dec 17;312(23):2521-30. doi: 10.1001/jama.2014.15704. JAMA. 2014. PMID: 25514302 Clinical Trial.
Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy.
Ho EY, Yau T, Rousseau F, Heathcote EJ, Lau GK. Ho EY, et al. Hepatol Int. 2015 Apr;9(2):224-30. doi: 10.1007/s12072-015-9612-6. Epub 2015 Mar 12. Hepatol Int. 2015. PMID: 25788197 Clinical Trial.
Antiviral therapies for managing viral hepatitis in lymphoma patients.
Merli M, Rattotti S, Gotti M, Arcaini L. Merli M, et al. Expert Opin Pharmacother. 2017 Mar;18(4):363-376. doi: 10.1080/14656566.2017.1288718. Epub 2017 Feb 15. Expert Opin Pharmacother. 2017. PMID: 28140702 Review.

See all similar articles

Cited by

Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma.
Borojevic B, Chauhan A, Patterson S. Borojevic B, et al. BMJ Case Rep. 2021 Jul 9;14(7):e243526. doi: 10.1136/bcr-2021-243526. BMJ Case Rep. 2021. PMID: 34244190 Free PMC article. Review.
Correspondence in reference to the previously published Epub manuscript: "Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677".
Picardi M, Giordano C, Roberta DP, Pugliese N, Leone A, Gentile G, Pane F. Picardi M, et al. Ann Hematol. 2021 Jun;100(6):1631-1633. doi: 10.1007/s00277-021-04436-9. Epub 2021 Feb 1. Ann Hematol. 2021. PMID: 33521863 Free PMC article. No abstract available.
Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma.
Tsukune Y, Sasaki M, Komatsu N. Tsukune Y, et al. Cancers (Basel). 2019 Nov 19;11(11):1819. doi: 10.3390/cancers11111819. Cancers (Basel). 2019. PMID: 31752356 Free PMC article. Review.
Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation.
Toka B, Koksal AS, Eminler AT, Tozlu M, Uslan MI, Parlak E. Toka B, et al. Dig Dis Sci. 2021 Jul;66(7):2417-2426. doi: 10.1007/s10620-020-06506-w. Epub 2020 Jul 29. Dig Dis Sci. 2021. PMID: 32729014 Clinical Trial.
Prevention Strategies to Minimize the Infection Risk Associated with Biologic and _targeted Immunomodulators.
Kordzadeh-Kermani E, Khalili H, Karimzadeh I, Salehi M. Kordzadeh-Kermani E, et al. Infect Drug Resist. 2020 Feb 18;13:513-532. doi: 10.2147/IDR.S233137. eCollection 2020. Infect Drug Resist. 2020. PMID: 32110062 Free PMC article. Review.

See all "Cited by" articles

References

1. Yeo W, Zee B, Zhong S, et al. . Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer. 2004;90(7):1306-1311. - PMC - PubMed
1. Law MF, Ho R, Cheung CKM, et al. . Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy. World J Gastroenterol. 2016;22(28):6484-6500. - PMC - PubMed
1. Perrillo RP, Gish R, Falck-Ytter YT. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015;148(1):221-244.e3. - PubMed
1. Lampertico P, Agarwal K, Berg T, et al. ; European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370-398. - PubMed
1. Zhang M-Y, Zhu G-Q, Shi K-Q, et al. . Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation. Onco_target. 2016;7(21):30642-30658. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

NODES